These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
22. Detection of prenatal drug exposure in the pregnant woman and her newborn infant. Ostrea EM. NIDA Res Monogr; 1992 Dec; 117():61-79. PubMed ID: 1620211 [No Abstract] [Full Text] [Related]
26. Confirmation of cocaine use during pregnancy: a critical review. Ursitti F, Klein J, Koren G. Ther Drug Monit; 2001 Aug; 23(4):347-53. PubMed ID: 11477315 [No Abstract] [Full Text] [Related]
27. Prevalence of cocaine and marijuana use in the last trimester of adolescent pregnancy: socio-demographic, psychosocial and behavioral characteristics. Mitsuhiro SS, Chalem E, Barros MC, Guinsburg R, Laranjeira R. Addict Behav; 2007 Feb; 32(2):392-7. PubMed ID: 16814936 [Abstract] [Full Text] [Related]
30. Constitutional law: Fourth Circuit upholds cocaine testing of pregnant women. Dubin JM. J Law Med Ethics; 1999 Feb; 27(3):279-81. PubMed ID: 11067607 [No Abstract] [Full Text] [Related]
31. Testing for fetal exposure to illicit drugs using umbilical cord tissue vs meconium. Montgomery D, Plate C, Alder SC, Jones M, Jones J, Christensen RD. J Perinatol; 2006 Jan 01; 26(1):11-4. PubMed ID: 16281047 [Abstract] [Full Text] [Related]
33. Screening for substance use in pregnancy: a practical approach for the primary care physician. Chasnoff IJ, Neuman K, Thornton C, Callaghan MA. Am J Obstet Gynecol; 2001 Mar 01; 184(4):752-8. PubMed ID: 11262483 [Abstract] [Full Text] [Related]
34. Detection of benzodiazepine abuse in opiate addicts. Browne R, Sloan D, Fahy S, Keating S, Moran C, O'Connor J. Ir Med J; 1998 Mar 01; 91(1):18-9. PubMed ID: 9563249 [Abstract] [Full Text] [Related]
36. The challenges of screening for substance use in pregnant women: commentary on the 4P'S Plus tool. Jones HE. J Perinatol; 2005 Jun 01; 25(6):365-7. PubMed ID: 15915163 [No Abstract] [Full Text] [Related]